Evidence about medicines: our engagement with stakeholders

As part of our workstream on ‘Enhancing the use of scientific evidence to judge the potential benefits and harms of medicines’, the Academy engaged widely with a range of stakeholders.

Launched

This stakeholder engagement was part of our workstream on ‘Enhancing the use of scientific evidence to judge the potential benefits and harms of medicines’. Please visit our workstream policy project page for more information.

A programme of public and stakeholder engagement took place throughout the ‘Enhancing the use of scientific evidence to judge the potential benefits and harms of medicines’ project to ensure discussions were informed by the views of wider society. It included a programme of activities that engaged the public, patients and healthcare professionals in a deliberative dialogue to explore how individuals perceive and interpret medical scientific evidence.

The dialogue aimed to identify how evidence should be communicated, what the role of professionals are in this process, how individuals’ views of evidence are influenced by health beliefs, and what forms of evidence influence health decision-making.

 

 

Staff leads


Symposium on medical imaging and artificial intelligence

Book Now

Real world evidence scoping roundtable

Book Now

Human Challenge Studies workshop

Book Now
View more